Quarterly report pursuant to Section 13 or 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
 3 Months Ended
Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activities
Following is a summary of stock option activities for the three months ended March 31, 2023:
Options Weighted
Average
Exercise Price
Weighted
Average
Grant Date
Fair Value
Weighted
Average
Remaining
Life
(years)
Intrinsic
Value
Outstanding – January 1, 2023 7,603,864  $ 0.19  $ 0.21  4.6 $ 25,795 
Granted —  —  — 
Exercised (300,785) 0.18  0.24 
Forfeited —  —  — 
Outstanding – March 31, 2023
 7,303,079  $ 0.19  $ 0.21  4.3 $ 23,312 
Exercisable as of March 31, 2023
 7,303,079  $ 0.19  $ 0.21  4.3 $ 23,312 
Summary of Restricted Stock Activity

Restricted Stock Units
Weighted Average Grant Date
Fair Value
Non-vested – January 1, 2023 7,466,636  $ 5.52 
Granted
 177,389  3.26 
Vested
 (160,237) 8.09 
Forfeited
 (24,751) 6.49 
Non-vested – March 31, 2023
 7,459,037  $ 5.41 
Summary of Stock-based Compensation Expense
Stock-based compensation expense for stock options and restricted stock units in the unaudited interim condensed consolidated statements of operations is summarized as follows:
Three Months Ended
March 31,
2023 2022
Software development
 $ 168  $ 275 
General and administrative(1)
 2,636  1,723 
Selling and marketing
 78  100
Total stock-based compensation expense
 $ 2,882  $ 2,098 
________
(1) For the three months ended March 31, 2023, the Company includes a credit of $339 in connection with the settlement of the equity-based portion of Trinity’s contingent consideration that was paid in 2023 in respect of 2022 results.